Valuation Stories

Is AIRIQ INC outlook positive for August 2020?

  4 hours ago at Macroaxis 
By Ellen Johnson
In this story, I am going to address all latest AIRIQ INC shareholders considering to hold on to their positions in AIRIQ INC. I will analyze why, despite the latest dip, the longer-term fundamental drivers of the firm are still sound. Is the stock current valuation justified? We will cover AIRIQ INC valuation to give you a better outlook on taking a position in this stock. ... [more]
Valuation Ideas
AIRIQ INC has a current ratio of 2.11, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. The firm shows a Beta (market volatility) of 0.1771, which signifies not very significant fluctuations relative to the market. Let's try to break down what AIRIQ's beta means in this case. As returns on the market increase, AIRIQ INC returns are expected to increase less than the market. However, during the bear market, the loss on holding AIRIQ INC will be expected to be smaller as well. Even though it is essential to pay attention to AIRIQ INC historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. AIRIQ INC exposes twenty-one different technical indicators, which can help you to evaluate its performance. AIRIQ INC has an expected return of -0.1008%. Please be advised to confirm AIRIQ INC treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if AIRIQ INC stock performance from the past will be repeated in the future.
<div class='circular--portrait-small' style='font-weight: 700;background:#8B008B;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>AT</div>
  9 hours ago at Macroaxis 
By Vlad Skutelnik
In today's thesis, we are going to go over some ideas for Addex Therapeutics investors who consider a position in the company. We will inspect the possibilities of making Addex Therapeutics into a steady grower in August. Is Addex Therapeutics current valuation justified for 2020? Here i will cover my perspective on the firm valuation to give investors a better outlook on taking a position in the stock. What is Addex Therapeutics probability of distress for August 2020? What is Addex Therapeutics Target Price Odds to finish over Current Price? Proceeding from a normal probability distribution, the odds of Addex Therapeutics to move above the current price in 30 days from now is near 1%. The Addex Therapeutics probability density function shows the probability of Addex Therapeutics Stock to fall within a particular range of prices over 30 days. Given the investment horizon of 30 days, Addex Therapeutics has a beta of 0.277 . This suggests as returns on the market go up, Addex Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Addex Therapeutics will be expected to be much smaller as well. Moreover, the company has an alpha of 1.0334, implying that it can generate a 1.03 percent excess return over DOW after adjusting for the inherited market risk (beta).
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:0.9em;padding-top: 12px;;'>SAT</div>
  10 hours ago at Macroaxis 
By Ellen Johnson
In this story, I am going to address all SATS shareholders. We will look into why despite regular market tumult, the longer-term fundamental drivers of the firm are still sound. Is the firm current valuation justified for 2020? Here i will cover my perspective on SATS LTD valuation to give investors a better outlook on taking a position in the stock. What is SATS probability of distress for August 2020? What is SATS Target Price Odds to finish over Current Price? Based on a normal probability distribution, the odds of SATS to move above the current price in 30 days from now is about 56.11%. The SATS LTD probability density function shows the probability of SATS OTC Stock to fall within a particular range of prices over 30 days. Assuming the 30 trading days horizon, SATS has a beta of 0.0765 . This usually implies as returns on the market go up, SATS average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding SATS LTD will be expected to be much smaller as well. Additionally, the company has an alpha of 0.088, implying that it can generate a 0.088 percent excess return over DOW after adjusting for the inherited market risk (beta).
<div class='circular--portrait-small' style='font-weight: 700;background:#000000;color: #f2f2f2;font-size:1.1em;padding-top: 10px;;'>VG</div>
  13 hours ago at Macroaxis 
By Ellen Johnson
In this post, I will digest Virgin Galactic. We will look into why despite regular market tumult, the longer-term fundamental drivers of the firm are still sound. Is the firm valuation sustainable? Here I will cover Virgin Galactic Holdings perspective on valuation to give you a better outlook on taking a position in this stock. We estimate Virgin Galactic as currently overvalued. The real value is approaching 15.93 per share. What is Virgin Galactic Target Price Odds to finish over Current Price? Based on a normal probability distribution, the odds of Virgin Galactic to move above the current price in 30 days from now is roughly 2.6%. The Virgin Galactic Holdings probability density function shows the probability of Virgin Galactic Stock to fall within a particular range of prices over 30 days. Given the investment horizon of 30 days, Virgin Galactic Holdings has a beta of -0.2316 . This usually implies as returns on benchmark increase, returns on holding Virgin Galactic are expected to decrease at a much lower rate. During the bear market, however, Virgin Galactic Holdings is likely to outperform the market. Additionally, the company has an alpha of 0.9772, implying that it can generate a 0.98 percent excess return over DOW after adjusting for the inherited market risk (beta).
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>GI</div>
  15 hours ago at Macroaxis 
By Vlad Skutelnik
Is the firm current valuation justified for 2020? Here i will cover my perspective on Graf Industrial Corp valuation to give investors a better outlook on taking a position in the stock. What is Graf Industrial probability of financial unrest for August 2020? What is Graf Industrial Target Price Odds to finish over Current Price? Based on a normal probability distribution, the odds of Graf Industrial to move above the current price in 30 days from now is near 1%. The Graf Industrial Corp probability density function shows the probability of Graf Industrial Stock to fall within a particular range of prices over 30 days. Given the investment horizon of 30 days, Graf Industrial Corp has a beta of -0.2428 . This usually indicates as returns on benchmark increase, returns on holding Graf Industrial are expected to decrease at a much lower rate. During the bear market, however, Graf Industrial Corp is likely to outperform the market. Moreover, the company has an alpha of 1.3093, implying that it can generate a 1.31 percent excess return over DOW after adjusting for the inherited market risk (beta).
<div class='circular--portrait-small' style='font-weight: 700;background:#FF0000;color: #F5FFFA;font-size:1.1em;padding-top: 10px;;'>AL</div>
  19 hours ago at Macroaxis 
By Raphi Shpitalnik
Today I will review Altimmune. We will break down why Altimmune private investors may need to re-consider a stake in the firm. Is Altimmune valuation justified? Here I will also cover 2020 perspective on the current valuation of the entity to give you a better outlook on taking a possible position in this stock. What is Altimmune probability of distress for August 2020? What is Altimmune Target Price Odds to finish over Current Price? Attributed to a normal probability distribution, the odds of Altimmune to move above the current price in 30 days from now is near 1%. The Altimmune probability density function shows the probability of Altimmune Stock to fall within a particular range of prices over 30 days. Considering the 30-days investment horizon, Altimmune has a beta of 0.9011 . This suggests Altimmune market returns are related to returns on the market. As the market goes up or down, Altimmune is expected to follow. In addition to that, the company has an alpha of 2.0957, implying that it can generate a 2.1 percent excess return over DOW after adjusting for the inherited market risk (beta).
<div class='circular--portrait-small' style='font-weight: 700;background:#689CFD;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>CT</div>
  a day ago at Macroaxis 
By Raphi Shpitalnik
Is the company current valuation justified for 2020? Here i will cover my perspective on Capstone Turbine valuation to give investors a better outlook on taking a position in the stock. What is Capstone Turbine chance of bankruptcy for August 2020? What is Capstone Turbine Target Price Odds to finish over Current Price? Attributed to a normal probability distribution, the odds of Capstone Turbine to move above the current price in 30 days from now is under 4%. The Capstone Turbine probability density function shows the probability of Capstone Turbine Stock to fall within a particular range of prices over 30 days. Given the investment horizon of 30 days, Capstone Turbine has a beta of -0.0999 suggesting as returns on benchmark increase, returns on holding Capstone Turbine are expected to decrease at a much lower rate. During the bear market, however, Capstone Turbine is likely to outperform the market. Moreover, the company has an alpha of 1.916, implying that it can generate a 1.92 percent excess return over DOW after adjusting for the inherited market risk (beta).
<div class='circular--portrait-small' style='font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;padding-top: 10px;;'>HO</div>
  a day ago at Macroaxis 
By Raphi Shpitalnik
Is Helen Of Troy valuation justified? Here we go over the entity perspective on valuation to give you a better outlook on taking a position in this stock. Helen Of Troy Piotroski F Score is 4 - Ordinary. What is Helen Of Target Price Odds to finish over Current Price? Based on a normal probability distribution, the odds of Helen Of to move above the current price in 30 days from now is about 6.39%. The Helen Of Troy probability density function shows the probability of Helen Of Stock to fall within a particular range of prices over 30 days. Given the investment horizon of 30 days, Helen Of Troy has a beta of -0.4296 . This usually indicates as returns on benchmark increase, returns on holding Helen Of are expected to decrease at a much lower rate. During the bear market, however, Helen Of Troy is likely to outperform the market. Additionally, the company has an alpha of 0.7222, implying that it can generate a 0.72 percent excess return over DOW after adjusting for the inherited market risk (beta).
<div class='circular--portrait-small' style='font-weight: 700;background:#169D0B;color: #E6E6FA;font-size:1.1em;padding-top: 10px;;'>KH</div>
  2 days ago at Macroaxis 
By Raphi Shpitalnik
This article is aimed at all current or potential KUSHCO HOLDINGS investors. We will look into why albeit cyclical market disturbance, the long term basic indicators of the company are still strong. Is the firm valuation justified? Here I will also cover 2020 perspective on the current valuation of KUSHCO HOLDINGS INC to give you a better outlook on taking a possible position in this stock. What is KUSHCO HOLDINGS odds of distress for August 2020? What is KUSHCO HOLDINGS Target Price Odds to finish over Current Price? Depending on a normal probability distribution, the odds of KUSHCO HOLDINGS to move above the current price in 30 days from now is about 56.62%. The KUSHCO HOLDINGS INC probability density function shows the probability of KUSHCO HOLDINGS OTC Stock to fall within a particular range of prices over 30 days. Given the investment horizon of 30 days, KUSHCO HOLDINGS INC has a beta of -0.985 . This indicates Moreover, the company has an alpha of 1.0249, implying that it can generate a 1.02 percent excess return over DOW after adjusting for the inherited market risk (beta).
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>EI</div>
  2 days ago at Macroaxis 
By Raphi Shpitalnik
In today's thesis, we are going to go over some ideas for EXFO Inc investors who consider a position in the company. We will inspect the possibilities of making EXFO Inc into a steady grower in August. What is the company valuation so far in 2020? We are going to cover EXFO Inc perspective on valuation to give investors a better transparency on taking a position in this stock. EXFO Inc current chance of bankruptcy is under 10%. Will the entity executives continue to add value? What is EXFO Inc Target Price Odds to finish over Current Price? Proceeding from a normal probability distribution, the odds of EXFO Inc to move above the current price in 30 days from now is about 5.86%. The EXFO Inc Subordinate probability density function shows the probability of EXFO Inc Stock to fall within a particular range of prices over 30 days. Given the investment horizon of 30 days, EXFO Inc has a beta of 0.5083 suggesting as returns on the market go up, EXFO Inc average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding EXFO Inc Subordinate will be expected to be much smaller as well. Additionally, the company has an alpha of 0.2259, implying that it can generate a 0.23 percent excess return over DOW after adjusting for the inherited market risk (beta).
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page